While clinical trials have shown cardiovascular benefits with semaglutide, it is not licensed in the UK for cardiovascular risk reduction
Losing weight may improve blood pressure, blood sugar, and heart disease risk, but if the journey comes with emotional struggles, those victories can feel hollow
Retinols are like typing in one of the many passwords you have, hoping you picked the right one
SURMOUNT-5: the definitive comparison SURMOUNT-5 is the first large-scale, randomized, controlled trial directly comparing tirzepatide and semaglutide for obesity treatment
Your provider will likely perform a urinalysis, assess kidney function through blood tests (creatinine, estimated glomerular filtration rate), and evaluate blood glucose control with hemoglobin A1c or glucose monitoring
Are there opportunities for product expansion or product tailoring to these users